163 related articles for article (PubMed ID: 37996489)
21.
Huang Y; Lin A; Gu T; Hou S; Yao J; Luo P; Zhang J
Immunotherapy; 2023 Oct; 15(15):1275-1291. PubMed ID: 37584225
[No Abstract] [Full Text] [Related]
22. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
Liang L; Mai S; Mai G; Chen Y; Liu L
Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
[TBL] [Abstract][Full Text] [Related]
23. Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.
Li H; Sun X; Zhao Y; Zhang C; Jiang K; Ren J; Xing L; He M
BMC Cancer; 2023 Jun; 23(1):528. PubMed ID: 37296415
[TBL] [Abstract][Full Text] [Related]
24. Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
Zeng Y; Zeng Y; Yin H; Chen F; Wang Q; Yu X; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):3459-3482. PubMed ID: 33428606
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of necroptotic patterns and associated immune landscapes in individualized treatment of skin cutaneous melanoma.
Yang B; Xie P; Huai H; Li J
Sci Rep; 2023 Nov; 13(1):21094. PubMed ID: 38036577
[TBL] [Abstract][Full Text] [Related]
26. Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.
Zhao Y; Wei Y; Fan L; Nie Y; Li J; Zeng R; Li J; Zhan X; Lei L; Kang Z; Li J; Zhang W; Yang Z
Mol Med; 2023 Oct; 29(1):145. PubMed ID: 37884883
[TBL] [Abstract][Full Text] [Related]
27. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.
Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J
Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
29. A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.
Huang R; Mao M; Lu Y; Yu Q; Liao L
Aging (Albany NY); 2020 Apr; 12(8):6966-6980. PubMed ID: 32310824
[TBL] [Abstract][Full Text] [Related]
30. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
Liu C; Liu Y; Yu Y; Zhao Y; Yu A
BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
[TBL] [Abstract][Full Text] [Related]
32. Prognostic signature and immune efficacy of m
Wu XR; Chen Z; Liu Y; Chen ZZ; Tang F; Chen ZZ; Li JJ; Liao JL; Cao K; Chen X; Zhou J
J Cell Mol Med; 2021 Sep; 25(17):8405-8418. PubMed ID: 34288419
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
[TBL] [Abstract][Full Text] [Related]
34. Characterization the prognosis role and effects of snoRNAs in melanoma patients.
Wang LY; Song JN; Chen YX; Zhu Y; Ren HL; Li QQ; Zhang SH
Exp Dermatol; 2024 Jan; 33(1):e14944. PubMed ID: 37772659
[TBL] [Abstract][Full Text] [Related]
35. SMG7-AS1 as a prognostic biomarker and predictor of immunotherapy responses for skin cutaneous melanoma.
Xu X; Ju Y; Zhao X; Yang P; Zhu F; Fang B
Genomics; 2023 May; 115(3):110614. PubMed ID: 36931476
[TBL] [Abstract][Full Text] [Related]
36. Necroptosis-associated classification combined with tumor microenvironment characteristic analysis of cutaneous melanoma.
Hu G; Jiang Y; Ma J; Zhan H
Sci Rep; 2022 May; 12(1):8752. PubMed ID: 35610275
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
38. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
39.
Liu Z; Li J; Hu X; Xu H
J Gastrointest Oncol; 2021 Jun; 12(3):1058-1073. PubMed ID: 34295557
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA.
Zhang M; Yang L; Wang Y; Zuo Y; Chen D; Guo X
Sci Rep; 2023 May; 13(1):7299. PubMed ID: 37147395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
